Tag Archives: Needham

Top Analyst Bullish on Mobileye’s Vehicle Testing

Five-star Needham analyst Rajvindra Gill has reiterated his buy rating for Mobileye (NYSE: MBLY) following the announcement that Mobileye will test 40 flagship BMW 7 series Level 4 vehicles in the USA and Europe in 2H17. Mobileye has partnered with

Teleflex Acquires Vascular Solutions Inc. (VASC) Near its All-Time High

Popular medical device company, Vascular Solutions Inc. (NASDAQ: VASC) has been in the spotlight recently due to rumors of a possible acquisition. The rumors were proved to be true when a deal valued at $1 Billion was inked between medical-device

Synaptics Inc. Receives a Buy from Needham

In a report released today, Rajvindra Gill from Needham reiterated a Buy rating on Synaptics Inc. (NASDAQ: SYNA), with a price target of $65. The company’s shares opened today at $65.17. Gill wrote, “Synaptics announced today that its TDDI technology

Needham Reiterates a Buy Rating on Alnylam Pharma

In a report released today, Alan Carr from Needham reiterated a Buy rating on Alnylam Pharma (NASDAQ: ALNY), with a price target of $137. The company’s shares closed yesterday at $70.30. According to TipRanks.com, Carr is a 5-star analyst with

Needham Throws Light on Sunny Optical

Research

Sunny Optical Technology (Group) Co. Ltd (HKG: 2382) stock fell over 9.6% in the last four weeks as they delivered a lower than estimated first half of 2016 results. But, Needham & Company’s analyst Rajvindra S. Gill conducted a third

Needham Reiterates a Buy Rating on Monolithic Power

Needham analyst Quinn Bolton reiterated a Buy rating on Monolithic Power (NASDAQ: MPWR) today and set a price target of $87. The company’s shares closed yesterday at $76.45, close to its 52-week high of $78.45. Bolton noted, “We hosted the